|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.7 TWD | +0.52% |
|
+2.11% | -14.91% |
Sea Mild Biotechnology Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 202.65 million compared to TWD 163.82 million a year ago. Net loss was TWD 21.38 million compared to TWD 52.05 million a year ago.
Basic loss per share from continuing operations was TWD 1.11 compared to TWD 2.7 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.91% | 5.76M | |
| -16.86% | 40.61B | |
| +13.56% | 26.39B | |
| -14.73% | 7.23B | |
| +4.17% | 5.89B | |
| -6.14% | 3.07B | |
| -1.99% | 2.26B | |
| -6.29% | 1.97B | |
| +28.19% | 966M | |
| +3.17% | 666M |
SEA MILD BIOTECHNOLOGY CO., LTD. 